Athanasios Yiotakis

RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites

Vincent Dive, Jöel Cotton, Athanasios Yiotakis et al. · Proceedings of the National Academy of Sciences · 1999 · 177 citations · Full text

Bioorganic Chemistry, Active Sites, Chemical Biology +18

A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E–Knockout Mice

Jason L. Johnson, Laurent Devel, Bertrand Czarny et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 171 citations · Full text

Roles of the Two Active Sites of Somatic Angiotensin-Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin

Dimitris Georgiadis, Fabrice Beau, Bertrand Czarny et al. · Circulation Research · 2003 · 154 citations · Full text

Functional Active Site, Molecular Pharmacology, Signal Transduction +15

Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12

Laurent Devel, Vassilis Rogakos, Arnaud David et al. · Journal of Biological Chemistry · 2006 · 146 citations · Full text

Matrix Metalloproteinase-12, Protein Function, Biochemistry +14

Crystal Structures of MMP-9 Complexes with Five Inhibitors: Contribution of the Flexible Arg424 Side-chain to Selectivity

A. Tochowicz, K. Maskos, Robert Huber et al. · Journal of Molecular Biology · 2007 · 140 citations

Mmp-9 Complexes, Engineering, Coordination Complex +6